The present report deals with the effect of adrenocortical steroid cases was evaluated with urinary 17-OHCSlevels after discontinuation of the treatment, type of response to ACTHand ll-/?-hydroxylase inhibitor, in general, no hypoadrenocorticism was encountered in cases which received therapy less than 3 months in duration, or in cases which took 200 to 300 tablets in the same period. However,, the treatment with higher doses or of longer period produced varying degree of hypoadrenocorticism ; generally, the larger the dose and the longer the duration of treatment the higher the degree of the impairment was observed.
